Board of Directors

Members of Board of Directors

	Iwan Williams Interim Chief Executive Iwan was appointed to the Board as Interim Chief Executive on 9th January 2008. Prior to joining Ransom he was President Europe, Africa and the Middle East for McCormick & Company Inc (‘McCormick’), the world leader in herbs, spices, seasonings and flavourings. Before joining McCormick he held senior positions with both Coca-Cola and S.C. Johnson. Iwan has extensive experience in brand management and the implementation of restructuring and cost reduction programmes.
	Ian Miscampbell Group Finance Director Ian Miscampbell, 45, was appointed to the Board in March 2007. Previously Finance Director at Oxford Immunotec Ltd. He was also previously Finance Director of Microscience Ltd and Finance Director and Chief Operating Officer of KS Biomedix Holdings plc. Before entering the healthcare sector, he gained significant experience in the food and textiles sectors, and worked at Bowmans in Hitchin, a local family run company, as Finance Director for some years.

Non-Executive Directors

	David Suddens, MA Non-Executive Chairman David Suddens, 59, was appointed to the Board as Non-Executive Director in February 2007 and Non-Executive Chairman in October 2007. He is Chief Executive of Griggs Group Ltd., licencees of the Doctor Martens footwear brand. He has held senior positions in both international marketing and manufacturing organisations.
	Tim Bridge, BA, DL Tim Bridge, 57, was appointed to the Board as a Non-Executive Director in April 2006. Tim has spent most of his working life at Greene King plc, rising to become Chief Executive in 1994. After more than 10 years overseeing the successful expansion of the business, he stepped aside and was appointed Chairman, a position he has held since May 2005. He is also a Non-Executive Director of Weatherbys Ventures ltd.

Committees

Remuneration Committee

The committee advises the Board on the setting of directors' remuneration and uses comparative remuneration surveys for companies of a similar size to arrive at its recommendations. The committee consists of Tim Bridge and David Suddens.

Audit Committee

The purpose of the Audit Committee is to consider any matters raised by the external auditors in connection with their work and findings, to review the scope and cost effectiveness of the audit and the independence and objectivity of the external auditors. It meets at least twice a year and consists of David Suddens and Tim Bridge.

Nomination Committee

The nomination committee consists of Tim Bridge and David Suddens. Its purpose is to consider the appointments or retirement of directors and to make recommendations thereon to the Board.